NCT01424891View on ClinicalTrials.gov

Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

August 31, 2011

Conditions
Type 2 DiabetesInflammation
Interventions
DRUG

Simvastatin 80 mg

treatment with 80 mg of simvastatin over a period of 8 weeks

DRUG

Sim10/Eze10

treatment with combination of simvastatin 10 mg and ezetimibe 10 mg

DRUG

Placebo

treatment with placebo over 8 weeks

Trial Locations (1)

69120

University Hospital of Heidelberg, Heidelberg

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01424891 - Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe | Biotech Hunter | Biotech Hunter